Analysen von Jo Walton
07.03.25 | Bayer Neutral | UBS AG | |
06.03.25 | Bayer Neutral | UBS AG | |
25.02.25 | Bayer Neutral | UBS AG | |
06.02.25 | GSK Neutral | UBS AG | |
05.02.25 | GSK Neutral | UBS AG | |
30.01.25 | GSK Neutral | UBS AG | |
20.12.24 | Novo Nordisk Neutral | UBS AG | |
16.12.24 | Novo Nordisk Neutral | UBS AG | |
Werbung
|
|||
09.12.24 | Novo Nordisk Neutral | UBS AG | |
02.12.24 | Novo Nordisk Neutral | UBS AG | |
21.11.24 | Bayer Neutral | UBS AG | |
18.11.24 | Novo Nordisk Neutral | UBS AG | |
13.11.24 | Bayer Neutral | UBS AG | |
13.11.24 | Novo Nordisk Neutral | UBS AG | |
12.11.24 | Bayer Neutral | UBS AG | |
11.11.24 | Novo Nordisk Neutral | UBS AG | |
07.11.24 | Novo Nordisk Neutral | UBS AG | |
07.11.24 | Bayer Neutral | UBS AG | |
06.11.24 | Novo Nordisk Neutral | UBS AG | |
06.11.24 | Novo Nordisk Neutral | UBS AG | |
04.11.24 | Novo Nordisk Neutral | UBS AG | |
31.10.24 | GSK Neutral | UBS AG | |
30.10.24 | GSK Neutral | UBS AG | |
28.10.24 | Novo Nordisk Neutral | UBS AG | |
21.10.24 | GSK Neutral | UBS AG | |
15.10.24 | Novo Nordisk Neutral | UBS AG | |
10.10.24 | GSK Neutral | UBS AG | |
03.10.24 | Novo Nordisk Neutral | UBS AG | |
20.09.24 | Novo Nordisk Neutral | UBS AG | |
11.09.24 | Novo Nordisk Neutral | UBS AG | |
02.09.24 | Bayer Neutral | UBS AG | |
09.08.24 | Novo Nordisk Neutral | UBS AG | |
07.08.24 | Bayer Neutral | UBS AG | |
07.08.24 | Novo Nordisk Neutral | UBS AG | |
06.08.24 | Bayer Neutral | UBS AG | |
02.08.24 | Bayer Neutral | UBS AG | |
01.08.24 | Novo Nordisk Neutral | UBS AG | |
01.08.24 | GSK Neutral | UBS AG | |
08.07.24 | GSK Neutral | UBS AG | |
28.06.24 | Novo Nordisk Neutral | UBS AG | |
17.05.24 | Bayer Neutral | UBS AG | |
15.05.24 | Bayer Neutral | UBS AG | |
15.05.24 | Novo Nordisk Neutral | UBS AG | |
14.05.24 | Novo Nordisk Neutral | UBS AG | |
14.05.24 | Bayer Neutral | UBS AG | |
02.05.24 | Novo Nordisk Neutral | UBS AG | |
29.04.24 | Novo Nordisk Neutral | UBS AG | |
12.04.24 | Bayer Neutral | UBS AG | |
26.03.24 | Novo Nordisk Neutral | UBS AG | |
11.03.24 | Novo Nordisk Neutral | UBS AG |